The Global Medical Tricorder Market size is expected to reach $7.7 billion by 2030, rising at a market growth of 9.1% CAGR during the forecast period.
Medical tricorders have become more sophisticated, accurate, and user-friendly as technology advances. European consumers and healthcare providers are increasingly interested in adopting these cutting-edge devices to improve patient care and health monitoring. Therefore, the European region would account for 2/5th share of the market by 2030. The rise of telemedicine and telehealth services in Europe has created a demand for tools that enable patients and healthcare providers to collect and share medical data remotely. Owing to these aspects, there will be a rise in demand in the Europe segment. Some of the factors impacting the market are rising technological advancements in medical devices, increasing proactive engagement of patients in managing their health, and strict regulatory requirements and the process of obtaining approvals.
Advances in sensor miniaturization have allowed for integrating various sensors into small, handheld devices. This includes sensors for measuring temperature, blood pressure, heart rate, and oxygen levels. These sensors are now compact, highly accurate, and energy-efficient. Modern sensors can detect subtle physiological parameter changes, making them suitable for clinical use. They can provide accurate measurements in real-time, which is crucial for monitoring health conditions and diagnosing illnesses. Tricorders can collect, process, and display health data in real-time, enabling immediate feedback to healthcare providers and patients. This real-time capability is crucial for making rapid clinical decisions and adjustments in treatment plans. Additionally, the need for devices and technology that help people track their health is growing as people take greater ownership of their health and well-being. Medical tricorders cater to this demand by providing a user-friendly, at-home health monitoring solution. Medical tricorders empower individuals to monitor their vital signs and health parameters regularly. This early detection of potential issues can lead to timely interventions and better health outcomes. With individuals actively using medical tricorders, a wealth of data is available for analysis. This data can be integrated into electronic health records, providing a more comprehensive view of a patient’s health history. It can also enable personalized healthcare recommendations and interventions based on the individual’s unique health data. Owing to these factors, the demand for medical tricorders will increase.
The pandemic disrupted global supply chains, impacting the production and distribution of medical tricorders. Delays in component sourcing and manufacturing occasionally hampered the availability of these devices, affecting healthcare facilities’ ability to access this technology. Moreover, the need for remote patient monitoring and diagnosis became more apparent during the pandemic, as healthcare facilities faced significant challenges in managing and treating COVID-19 patients. With their ability to remotely collect and transmit diagnostic data, medical tricorders saw increased demand to monitor patients without direct contact, reducing the risk of virus transmission. The urgent need for rapid and accurate diagnostic tools to identify COVID-19 cases also prompted innovation in the market.
However, the regulatory approval process can be time-consuming, often taking several years. This can significantly delay the development and commercialization of medical tricorders, slowing the introduction of new and innovative devices to the market. Complying with regulatory requirements often requires extensive testing, clinical trials, and documentation. These activities can significantly increase development costs, ultimately passed on to consumers through higher device prices. Small and innovative startups may face substantial challenges entering the market due to the high costs and complexities associated with regulatory approval. This can limit competition and innovation within the market.
Application Outlook
Based on application, the market is segmented into monitoring, diagnosis, and others. The diagnosis segment held the largest revenue share in the market in 2022. Medical tricorders have evolved to incorporate sensors capable of measuring vital signs and parameters. These sensors include electrocardiography (ECG), temperature, blood pressure, and respiratory rate. Integrating multi-modal sensors enhances tricorders’ diagnostic capabilities, allowing for comprehensive health assessments. The integration of nanotechnology and lab-on-a-chip technology has revolutionized diagnostics. Medical tricorders can now detect diseases, pathogens, and biomarkers with exceptional sensitivity at the molecular level. This level of precision enables early disease detection and monitoring, significantly improving patient outcomes. Therefore, these factors will boost the demand in the segment.
Type Outlook
By type, the market is divided into wireless, USB camera, fiber optic camera, corded, and others. In 2022, the corded segment acquired a considerable revenue share in the market. Corded tricorders offer higher accuracy and reliability due to the direct and consistent connection to power sources and data transmission. This can be crucial in medical diagnostics. Depending on the region, certain regulatory standards may require stringent data security and accuracy. Corded tricorders might be favored due to their compliance with such regulations. Corded tricorders have a continuous power supply and uninterrupted connectivity, eliminating concerns related to battery life or wireless connectivity issues. Wired connections can often provide faster and more stable data transfer speeds compared to wireless options. Therefore, these factors will boost the expansion of the corded segment.
End-user Outlook
On the basis of end-user, the market is divided into hospitals, clinics, and others. The hospitals segment recorded the maximum revenue share in the market in 2022. Hospitals and ambulatory surgical centers are keen on providing the best possible care to their patients. Medical tricorders offer improved diagnostic capabilities, allowing healthcare professionals to quickly and accurately diagnose various medical conditions. This technology is especially valuable in emergency rooms, where rapid diagnosis can be a matter of life and death. Medical tricorders can significantly streamline the workflow within healthcare facilities. They enable healthcare providers to collect diagnostic data rapidly and with minimal patient disruption. This efficiency is especially valuable in busy hospital settings and ambulatory surgical centers where time is often of the essence. Owing to these factors, there will be increased demand in the segment.
Regional Outlook
By region, the market is segmented into North America, Europe, Asia Pacific, and LAMEA. The North America segment procured the highest revenue share in the market in 2022. The North American population is aging, leading to an increased demand for healthcare services. Medical tricorders offer a more efficient and convenient way to monitor health conditions, which can reduce the burden on healthcare systems. Medical tricorders are useful for ongoing surveillance of long-term conditions such as diabetes, high blood pressure, and heart disease. With a growing number of people living with these conditions, the demand for effective remote monitoring tools is rising. Therefore, the segment will witness increased demand in the future.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Ltd., Ionis Pharmaceuticals, Inc., Fujikura Ltd., Basler AG, Qualcomm, Inc., Hamamatsu Photonics K.K., Basil Leaf Technologies, DynoSense Corp, Cloud DX Inc., and QuantuMDx Group Limited.
Strategies Deployed in Medical Tricorder Market
Oct-2023: Qualcomm, Inc. came into partnership with Alphabet’s Google, an American multinational technology company. This partnership aimed to manufacture wearable devices like smartwatches using chips based on RISC-V technology.
Jun-2023: Qualcomm Technologies, Inc. launched the Qualcomm Video Collaboration Platform, a new suite of video collaboration solutions. The launched product would enable original equipment manufacturers (OEMs) to design and deploy video conferencing products featuring superior video, audio, and customizable on-device AI to power engaging, immersive virtual meeting experiences across enterprise, healthcare, educational, and home environments.
May-2023: Ltd. came into collaboration with Boehringer Ingelheim Pharmaceuticals, Inc., a leading research-driven pharmaceutical company. This collaboration aimed to help at-home testing and provide educational information for patients at risk of chronic kidney disease (CKD).
Oct-2022: Cloud DX Inc. partnered with CBI Health, Canada’s leading community healthcare provider. This partnership aimed to integrate Cloud DX expertise in remote and virtual care with CBI Health’s professional and personal healthcare services and hospitals could discharge patients earlier with confidence.
Aug-2022: Cloud DX Inc. partnered with Teladoc Health, the global leader in whole-person virtual care. This partnership aimed to better serve the remote monitoring needs of patients across Canada.
Feb-2022: Ltd. partnered with Seed Group, a company of the private office of Sheikh Saeed bin Ahmed Al Maktoum. This partnership aimed to expand portfolios in the UAE.
Dec-2021: Cloud DX Inc. signed an agreement with Medtronic Canada ULC, a subsidiary of Medtronic plc. This agreement aimed to involve the enrollment of a chronic care or surgical patient onto the Connected HealthTM platform, generating recurring revenue, depending on the length of the monitoring program.
Dec-2020: Qualcomm, Inc. collaborated with trinamiX, a global solution provider specializing in Oracle Applications. This collaboration aimed to develop an IR spectrometer for smartphones, one step closer to Star Trek’s tricorders.
Sep-2020: Cloud DX Inc. unveiled an updated Connected Health Kit, alongside a new quick-start program. The launched product would allow health providers and care teams to widen remote patient monitoring quickly and cost-effectively.
Jun-2020: Ltd. acquired Inui Health., a smartphone urinalysis startup. Under this acquisition, both companies aimed to build their product around the existing dipstick and technology.
Scope of the Study
Market Segments covered in the Report:
By Application

    • Diagnosis
    • Monitoring
    • Others

By Type

  • • Wireless
    • USB Camera
    • Fiber Optic Camera
    • Corded
    • Others

By End User

  • • Hospitals
    • Clinics
    • Others

By Geography

  • • North America

o US
o Canada
o Mexico
o Rest of North America

  • • Europe

o Germany
o UK
o France
o Russia
o Spain
o Italy
o Rest of Europe

  • • Asia Pacific

o China
o Japan
o India
o South Korea
o Singapore
o Malaysia
o Rest of Asia Pacific

  • • LAMEA

o Brazil
o Argentina
o Saudi Arabia
o South Africa
o Nigeria
o Rest of LAMEA
Companies Profiled

  • • Ltd.
    • Ionis Pharmaceuticals, Inc.
    • Fujikura Ltd.
    • Basler AG
    • Qualcomm, Inc.
    • Hamamatsu Photonics K.K.
    • Basil Leaf Technologies
    • DynoSense Corp
    • Cloud DX Inc.
    • QuantuMDx Group Limited

Unique Offerings from KBV Research

  • • Exhaustive coverage
    • Highest number of market tables and figures
    • Subscription based model available
    • Guaranteed best price
    • Assured post sales research support with 10% customization free